Australia's most trusted
source of pharma news
Tuesday, 7 July 2026
Tuesday, 7 July 2026
Subscribe
Login
J&J to pull drug worldwide
Australia is losing another PBS drug with the supply of this long-standing treatment to be discontinued due to commercial viability and there is no other medicine with this active registered in Australia.
Novartis buys Aussie-backed firm
Pays more than $2 billion for an ADC biotech backed by Australian venture capital firm Brandon Capital
TODAY
Revenue soars 25% on broad listing
Patients and prescribers have wasted no time embracing the broad listing of immunotherapies, with use jumping straight away
TODAY
Who's been named GM... again?
Two years after stepping away from a GM role this executive is back at the top working for a new company
6 July
Blockbusters stuck in PBS limbo
Seven drugs recommended in March have been marked 'inactive' including two of the world's up-and-coming top-sellers
6 July
Pharma Wonderland opens in Sydney
$250 million plant expected to become one of the largest pharmaceutical manufacturing facilities in the Southern Hemisphere
3 July
Next era of blockbusters unveiled
The top 10 best-selling drugs for 2032 have been named. Find out who's risen up the rankings and who's vanished...
2 July
Latest Jobs
Logistics and Customer Service SpecialistLogistics PlannerTrade Marketing ManagerCustomer Service RepresentativeClinical Trial InvestigatorSenior Medical Receptionist - 2ICCustomer Service AdministratorClinical Trial Investigator36 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (24)
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Inside Sales Specialist - Melbourne
- Customer Service Representative - Perth
- Inside Sales Specialist - Sydney
- Inside Sales Specialist - Brisbane
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
Access & Reimbursement (1)
Clinical & Medical, R&D (6)
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
- Clinical Trial Investigator - Melbourne
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
Regulatory, Pharmacovigilance & QA (4)
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
Other (9)
New FY brings fresh career start
The new financial year kicks off with a round of job moves including promotions, departures and retirements
TODAY
Drug dropped from PBAC meeting
A new treatment will now be considered at a future PBAC meeting, with a pending TGA decision likely the reason
TODAY
Gene genius: Aussies nab awards
Four Australian companies have picked up prizes at the Asia Pacific Cell & Gene Therapy Excellence Awards. Find out who
6 July
MSAC delivers a No over price
Blow after Committee dishes a rejection saying it was unable to discern if this drug 'was good value for money'
6 July
Novartis hit with first generic
The first copycat of Novartis' drug and a new high strength of Ozempic are among a long list of medicines approved
6 July Approvals Action
Where next for six Country Heads?
ICYMI: Some of industry's biggest names are between jobs. Find out who plus the other most popular stories this week
3 July Your Week in 5 Minutes
Pharmas cut spend on patients
The latest MA transparency report reveals pharma's financial support to patient organisations, has dropped year-on-year
3 July
Haemophilia market heats up
A pegged blockbuster has been approved by the TGA with the company 'working with urgency' to ensure equitable access
3 July
Gamechanger stumps cost experts
Worth the cost? Nobody knows and patients are missing out because health systems can't accurately assess its cost-effectiveness
3 July
Did this pharma disparage a rival?
The European Commission has opened an antitrust investigation to assess if this pharma campaign disparaged a rival
2 July
Media frenzy bites AstraZeneca
A global decision to wind back a monthly hormone blocker has seen AstraZeneca Australia come under sustained fire in the media
2 July
TGA asking about radio pathways
Consultation opens on how pharmas experience regulatory pathways for radiopharmaceuticals in the real world
2 July
Top names lead closed-door event
Three well-known industry execs fronted a panel to discuss outsourcing as an increasingly important strategic growth lever
2 July
Butler fails to rule out PBS delisting
Dept calls for savage price cuts to two major drugs that treat almost half the Aussie patients suffering from MS
1 July